Khaled H S Barakat


Dr. Barakat is at the forefront of pioneering research aimed at developing innovative immunotherapy drugs targeting immune checkpoint proteins. As the leader of a distinguished multidisciplinary research team, he spearheads groundbreaking efforts in this crucial area of medical science.

With a Ph.D. in biophysics earned from the University of Alberta in 2012, Dr. Barakat brings a wealth of expertise to his role. Following his doctoral studies, he completed a prestigious postdoctoral fellowship in Professor Michael Houghton’s Lab, further honing his skills and knowledge in the field.

Throughout his illustrious career, Dr. Barakat has garnered numerous accolades and honors, including coveted fellowships from CIHR and AIHS, as well as recognition such as the UofA dissertation award, ACRI Studentship, and various distinction awards during his academic journey.

In addition to his research endeavors, Dr. Barakat serves as an editor for several esteemed scientific journals, contributing to the advancement of knowledge in his field. His lab receives support from esteemed funding agencies, including the Alberta Cancer Foundation, Li Ka Shing Applied Virology Institute, Natural Sciences and Engineering Research Council (NSERC), Li Ka Shing Institute of Virology, and IC-IMPACTS Centres of Excellence.

Through his groundbreaking research and leadership, Dr. Barakat is paving the way for new and improved immunotherapy treatments, offering hope to patients and transforming the landscape of cancer treatment and beyond.

Research Interests:

Molecular Modelling, Bioinformatics, Computer Programming Methods, Computer Architecture.

Open Access Journals

Recently Released Issues

Social Network

Loading ....
Loading ....
Loading ....

Abstracting and Indexing

Boffin Access use Crossref Similarity Check for averting plagiarism


Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to

Send Information

Subscribe to our Newsletter

Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.


We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.

Do you have an idea or suggestion that can influence the Open Access community? Send an email to: support@boffinaccess.org